Correlation Between Cumberland Pharmaceuticals and 06406RAV9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and 06406RAV9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and 06406RAV9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and BK 105 15 OCT 26, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and 06406RAV9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of 06406RAV9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and 06406RAV9.

Diversification Opportunities for Cumberland Pharmaceuticals and 06406RAV9

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Cumberland and 06406RAV9 is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and BK 105 15 OCT 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BK 105 15 and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with 06406RAV9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BK 105 15 has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and 06406RAV9 go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and 06406RAV9

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 3.96 times more return on investment than 06406RAV9. However, Cumberland Pharmaceuticals is 3.96 times more volatile than BK 105 15 OCT 26. It trades about 0.21 of its potential returns per unit of risk. BK 105 15 OCT 26 is currently generating about -0.21 per unit of risk. If you would invest  114.00  in Cumberland Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  26.00  from holding Cumberland Pharmaceuticals or generate 22.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  BK 105 15 OCT 26

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
BK 105 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BK 105 15 OCT 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 06406RAV9 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Cumberland Pharmaceuticals and 06406RAV9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and 06406RAV9

The main advantage of trading using opposite Cumberland Pharmaceuticals and 06406RAV9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, 06406RAV9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 06406RAV9 will offset losses from the drop in 06406RAV9's long position.
The idea behind Cumberland Pharmaceuticals and BK 105 15 OCT 26 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance